Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Pharmacogenomics|August 25, 2007
G>C SNP of thymidylate synthase with respect to colorectal cancerMilena Gusella, Roberto Padrini
Therapeutic Drug Monitoring|May 22, 2002
New limited sampling strategy for determining 5-fluorouracil area under the concentration-time curve after rapid intravenous bolusMilena Gusella, Eros Ferrazzi, Mariano Ferrari, et al.
Cellular Oncology (Dordrecht, Netherlands)|January 10, 2015
Germline oncopharmacogenetics, a promising field in cancer therapyChiara Pesenti, Milena Gusella, Silvia M Sirchia, et al.
British Journal of Clinical Pharmacology|September 5, 2002
Relationships between body composition parameters and fluorouracil pharmacokineticsMilena Gusella, Sivia Toso, Eros Ferrazzi, et al.
Therapeutic Drug Monitoring|November 25, 2005
Effect of hemodialysis on the metabolic clearance of 5-Fluorouracil in a patient with end-stage renal failureMilena Gusella, Mirca Rebeschini, Giuseppe Cartei, et al.
Clinical Pharmacology and Therapeutics|December 24, 2002
Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearanceMaria Gabriella Scordo, Vittorio Pengo, Edoardo Spina, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|June 5, 2003
Bioimpedance vector pattern in cancer patients without disease versus locally advanced or disseminated diseaseSilvia Toso, Antonio Piccoli, Milena Gusella, et al.
Pageof 3